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The combination of transcranial magnetic stimulation and electroencephalography
(TMS-EEG) has uncovered underlying mechanisms of two anti-epileptic medications:
levetiracetam and lamotrigine. Despite their different mechanism of action, both drugs
modulated TMS-evoked EEG potentials (TEPs) in a similar way. Since both medications
increase resting motor threshold (RMT), the current aim was to examine the similarities
and differences in post-drug TEPs, depending on whether stimulation intensity was
adjusted to take account of post-drug RMT increase. The experiment followed a
placebo controlled, double blind, crossover design, involving a single dose of either
lamotrigine or levetiracetam. When a drug-induced increase of RMT occurred, post-drug
measurements involved two blocks of stimulations, using unadjusted and adjusted
stimulation intensity. A cluster based permutation analysis of differences in TEP amplitude
between adjusted and unadjusted stimulation intensity showed that lamotrigine induced
a stronger modulation of the N45 TEP component compared to levetiracetam. Results
highlight the impact of adjusting stimulation intensity.
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INTRODUCTION
Levetiracetam and lamotrigine are two commonly prescribed anti-epileptic drugs (AEDs)
(Nicholas et al., 2012). Lamotrigine blocks voltage-gated sodium channels and stabilizes
their inactive state (Cheung et al., 1992), whilst levetiracetam inhibits the release of the
excitatory neurotransmitter by binding to synaptic vesicle protein SV2A (Lynch et al., 2004).
Electromyographic (EMG) responses to TMS indicate that lamotrigine and levetiracetam increase
the resting motor threshold (RMT) (Ziemann et al., 1996), a TMS-EMG parameter which reflects
neural membrane excitability and ion channel conductance (Ziemann et al., 1996; Solinas et al.,
2008).
The combination of TMS with electroencephalography (TMS-EEG) demonstrates a greater
potential to investigate effects of drugs directly at cortical level (Premoli et al., 2014a,b, 2016;
Darmani et al., 2016). Single-pulses delivered over the motor area at threshold intensity (100%
RMT) result in positive and negative deflections named TMS-evoked EEG potentials (TEP) which
may provide insights into brain connectivity (Ilmoniemi et al., 1997) and neurotransmission
(Premoli et al., 2014a). Recently, we used TMS-EEG to characterize the effects of single oral doses of
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lamotrigine and levetiracetam. Both AEDs increased the
N45 and suppressed the P180. This study also showed
the expected finding that these AEDs both increase RMT
(Premoli et al., 2016).
In studies examining the effects of drugs, it is conventional
to obtain TMS measurements in two sessions, pre-drug and
post-drug intake. Conventionally, TMS intensity is calibrated
against RMT in the pre-drug session and not adjusted in the
post-drug session, even if RMT has changed. Therefore, the
absolute stimulation intensity is the same between sessions
but the relative intensity (relative to RMT) may vary between
sessions. It could be equally valid to adjust RMT between sessions
so that the relative stimulation intensity is the same between
sessions but the absolute intensity may vary.
Sitting in the cognitive domain of TMS literature, the
non-linear effects of stimulation intensity on behavior are well-
known. A well-documented review provides details of how
stimulation parameters (i.e., intensity), brain state dependency,
and task characteristics impact cortical excitability and therefore
behavioral responses (Miniussi et al., 2013). For instance,
it has been shown that the impact of mental imagery
contrast on phosphene perception is strictly dependent on
TMS intensity (Cattaneo et al., 2011), which therefore affects
TMS assessment of visual cortical excitability. In line with
this view, a previous work demonstrated that, during visually
evoked neural activity in anaesthetized and paralyzed cats,
low intensity TMS has facilitatory effects on neural firing,
whereas high intensity TMS produces an opposite behavior
(Moliadze et al., 2003).
A similar problem may arise also in non-pharmacological
interventions, that by adopting neuromodulation techniques
such as repetitive TMS (i.e., rTMS), can induce RMT changes
(Muellbacher et al., 2000; Fitzgerald et al., 2002, 2006). It is
therefore a relevant issue to monitor and consider RMT changes
before and after pharmacological and non-pharmacological
stimulation protocols.
In our recent study, we presented data in which TMS
stimulation intensity was not adjusted in the post-drug condition
(Premoli et al., 2016). However, we also collected data in which
TMS intensity was adjusted according to RMT in the post-drug
session. Here, we examine whether observed effects on TEPs
following drug intake are partly dependent on adjustment of
post-drug TMS intensity to take account of the change in RMT.
MATERIALS AND METHODS
Experimental Procedure
Fifteen male subjects aged 19–34 years (mean age ± SD, 25.2
± 4.62 years) gave written informed consent before enrolment
in this study. One subject only was not able to complete the
TMS-EEG recording after the intake of lamotrigine; hence the
total number of subjects for this condition is fourteen. The study
was performed according to the Declaration of Helsinki and
approved by King’s College London Research Ethics Committee.
Specific subject information, TMS-EMG/-EEG equipment,
data processing, and analysis protocols were described in our
previous work (Premoli et al., 2016). The experiment followed
a pseudo-randomized, placebo controlled, double-blinded
crossover study design in which all subjects participated in three
separate sessions, at intervals of 1 week, to receive a single oral
dose of levetiracetam (3,000mg) or lamotrigine (300mg) or
placebo (Premoli et al., 2016). During each session, data were
collected before and 120min after drug intake. When a drug-
induced increase of RMT occurred, the post-drug measurements
involved two blocks of stimulations. In a randomized order, TEPs
were recorded at an unadjusted (100% pre-drug RMT = RMT1)
and adjusted (100% post-drug RMT = RMT2) stimulation
intensity. In our previous work we reported only the RMT1
condition (Premoli et al., 2016).
Following the relative frequency method (Groppa et al., 2012),
the RMTwas defined as the lowest stimulus intensity sufficient to
elicit an MEP of>50 µV peak-to-peak amplitude in at least 5 out
of 10 trials whilst the first dorsal interosseous (FDI) was relaxed.
Despite the common knowledge that 100% RMT can elicit no or
only miniature MEPs, we cannot completely exclude that TEPs
were not contaminated by somatosensory afferent signals from
muscle twitches, as assessed by recent studies (Fecchio et al., 2017;
Petrichella et al., 2017; Premoli et al., 2017).
The hotspot position and the edge of each coil’s wing were
marked on top of the EEG cap using a felt tip pen. Further,
the same experimenter conducted all the TMS-EEG sessions for
each participant and study session. Coil position and orientation
relative to the marked position were carefully monitored by the
experimenter throughout stimulation and corrected if necessary
(i.e., if the participant moved) (Premoli et al., 2016).
Details for the multistep procedure of TMS-EEG data
preprocessing are provided in our previous work (Premoli
et al., 2016). Independent component analysis (FastICA), as
implemented in FieldTrip following an approach based on
Korhonen et al. (2011) (http://www.fieldtriptoolbox.org/tutorial/
tms-eeg), was applied to remove TMS-related artifacts (i.e.,
cranial muscle response, recharging of capacitors, and related
exponential decay artifacts; Korhonen et al., 2011; Rogasch et al.,
2014; Herring et al., 2015) as well as further muscle and ocular
activity. The criteria for components removal were if their spatio-
temporal profile indicated the activation of temporal muscles by
a characteristic sinusoidal waveform post-TMS (with opposite
sign) over frontotemporal sites close to the temporal muscle
(Veniero et al., 2013; Rogasch et al., 2014; Herring et al., 2015;
Premoli et al., 2017). To note, in line with the recent work from
Casula and colleagues, FastICA can only attenuate decay artifacts
(Casula et al., 2017).
Five TEP components in accordance with the literature
(Premoli et al., 2014a, 2016) were studied: P25 [time of
interest TOI (15–35ms)], N45 (35–65ms), P70 (65–90ms), N100
(90–145ms), and P180 (145–300ms). TOIs were chosen on the
basis of the grand-averaged TEPs and kept identical during the
analysis of pre-drug and post-drug measurements and across
conditions. To analyze drug-induced modulation of TEPs, we
selected a region of interest (ROI) composed of 12 channels over
and around the stimulation site (left M1) and the corresponding
contralateral site (FC1, FC3, FC5, C1, C3, C5, CP1, CP3, CP5,
P5, P3, P1, FC2, FC4, FC6, C2, C4, C6, CP2, CP4, CP6, P2, P4,
and P6).
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Statistics
Multiple dependent sample t-test comparisons were separately
applied for each TOI in all the electrodes within the indicated
ROI to (i) test TEP amplitude modulations induced by
lamotrigine and levetiracetam (post-drug with RMT1 vs. pre-
drug; post-drug with RMT2 vs. pre-drug), to (ii) analyse the
effect of different stimulation intensities (post-drug with RMT2
vs. post-drug with RMT1), and to (iii) understand the interaction
of these two factors [levetiracetam (post-RMT2 minus post-
RMT1) vs. lamotrigine (post-RMT2 minus post-RMT1)]. To
correct for multiple comparisons (i.e., electrodes, time points),
and in line with our previous work (Premoli et al., 2016), we
conducted a non-parametric cluster-based permutation analysis
as implemented in FieldTrip (Maris and Oostenveld, 2007).
RESULTS
Effects of AEDs and Increased Stimulation
Intensities on TEPs
Lamotrigine and levetiracetam produced a significant RMT
increase as expected (Solinas et al., 2008; Premoli et al., 2016)
(Figure 1A, left panel); these data are explained in details
in our previous work (Premoli et al., 2016). Levetiracetam
and lamotrigine individual changes of RMT values showed
an increase in 11 and 13 subjects, respectively (Figure 1A,
right panel). We here present the results reported previously,
comparing post-drug with RMT1 (i.e., unadjusted) intensities
against pre-drug conditions (Premoli et al., 2016). Figure 1B
shows that both AEDs increased the amplitude of the N45 over
channels ipsilateral to the stimulated left M1 and suppressed the
P180 component over contralateral sites.
The cluster analysis did not show significant effects (p > 0.05)
between the pre-drug conditions showing high reproducibility
across sessions (Premoli et al., 2016). Cluster-based permutation
analysis was applied between post-RMT2 and pre-drug
conditions to test the effect of AEDs on TEPs recorded with
adjusted stimulation intensity. Levetiracetam increased the
N45 amplitude (n = 15, p = 0.007) and suppressed the P70
amplitude (n= 15, p< 0.01) on channels close to the stimulation
site. Levetiracetam showed a trend for the suppression of the
P180 (p = 0.057). In contrast, lamotrigine suppressed only the
P180 amplitude (n = 15, p = 0.04) over ipsilateral channels
(Figure 1C). Finally, no significant differences were observed
after placebo (p > 0.05).
Effect of Stimulation Intensities
To investigate the effects of the increased stimulation intensity,
we compared post-drug using RMT2 vs. post-drug using RMT1.
For levetiracetam, TEPs resulting from adjusted stimulation
intensity (RMT2) compared to unadjusted RMT1 showed
increased N100 over channels close to the stimulation site
(p < 0.01; Figure 2A). In contrast, post-lamotrigine RMT2
compared to an unadjusted RMT1 demonstrated increased P25
amplitude (p < 0.01; Figure 2A) and augmented N45 amplitude
(p < 0.01; Figure 2A) over contralateral areas. In the placebo
condition there were no significant differences (p > 0.05).
Interaction between Stimulation Intensity
and AEDs Effects
Finally, we explored the interaction between stimulation
intensity and the different medications. To address
this, we compared intensity-induced changes in TEPs
(post-RMT2minus post-RMT1 intake) between drug conditions.
The comparison showed that, when stimulating at higher
intensities, lamotrigine induced a greater modulation of the N45
over contralateral channels (p < 0.01, Figure 2B) compared to
levetiracetam.
DISCUSSION
We have recently demonstrated that, despite the different
mechanism of action that lamotrigine and levetiracetam exert at
the molecular level, both AEDs impact the TMS-EEG response
in a similar way. The modulation induced by lamotrigine and
levetiracetam on TEPs recorded with unadjusted stimulation
intensity consisted of an increased amplitude of the N45 and
a suppressed P180 (Premoli et al., 2016). We here sought to
investigate the impact of increased stimulation intensity, adjusted
because of post-drug increased RMT, when assessing AEDs
effects on TMS-evoked EEG responses. We found that the N100
component was altered by the higher intensity of the RMT2
condition compared to RMT1 for levetiracetam, whereas P25
and N45 were altered in a specific way in the RMT2 condition
compared to RMT1 for lamotrigine. When we compared the
effect of RMT2 vs. RMT1 between drugs, we found that the N45
potential was affected. Therefore, the effect of drugs on TEPs
differs depending on whether absolute stimulation intensity or
relative stimulation intensity is held constant between pre- and
post-drug conditions.
TMS stimulation at higher intensity can produce a stronger
neuronal activity measured with EEG. It has been shown
that the amplitudes of N45 depended on intensity in a non-
linear manner, while the amplitude of the N100 and P180
components was rather linear. Further, these changes occurred
in the same cortical structures independently of stimulus
intensities (Komssi et al., 2004). Our results suggest that when
stimulation intensity is adjusted to take account of increased
post-drug RMT, the effects of lamotrigine and levetiracetam on
TEPs differ compared to the unadjusted condition. Comparison
between stimulation intensities for levetiracetam showed a
suppression of the difference curve (post-RMT2 minus post-
RMT1) toward the baseline, thus indicating that levetiracetam
exerts the same modulation independently of the stimulation
intensity for each potential. Conversely, at adjusted RMT values,
lamotrigine induces a larger N45 potential, a component which
is associated with GABA-A receptor (GABAAR) mediated
inhibitory neurotransmission (Premoli et al., 2014a,b; Darmani
et al., 2016). This result raises two crucial questions: why
does the modulation affect specifically the N45 component,
which has been related to GABAAR activity (Premoli et al.,
2014a,b; Darmani et al., 2016)? Why does lamotrigine show
a greater modulation at adjusted (i.e., increased) stimulation
intensities?
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FIGURE 1 | Left part of (A) shows RMT-values given as % of Maximum Stimulator Output (MSO) pre (blue = RMT1) and post (red = RMT2) the intake of levetiracetam
(LEV), lamotrigine (LTG), and placebo (PBO). The right part shows individual RMT values (expressed as % MSO) before and after the intake of each drug condition. (B)
TEPs recorded pre (blue) and post-RMT1 (red; unadjusted intensity) intake of levetiracetam (LEV, left) and lamotrigine (LTG, right). Levetiracetam and lamotrigine
increased the N45 over the left hemisphere and decreases the P180 component over channels contralateral to the stimulated left M1. Adapted from Premoli et al.
(2016). (C) TEPs recorded pre (blue) and post-RMT2 (red; adjusted intensity) intake of levetiracetam (LEV, left) and lamotrigine (LTG, right). Levetiracetam increased the
N45 and decreased the P70, while lamotrigine suppressed the P180. Effects are observed over the stimulated left hemisphere. Black asterisks underneath represent
significant drug-induced changes in TEPs. Shades indicate ± 1 SEM. T-statistic maps of the TEP amplitude post-drug vs. pre-drug differences are shown for each
comparison. Blue represents increase in negativity or reduced positivity. Each TEP plot shows the grand-average across significant channels which are indicated by
black dots in the t-statistic maps.
There is little evidence at present to answer these questions.
However, lamotrigine is often used as a mood stabilizer, in
addition to being a broad spectrum anti-convulsant. This could
be indicative of additional actions in the brain other than being
solely thought of as a traditional sodium-channel blocker. For
instance, lamotrigine has also been suggested to have an indirect
effect on GABAAR mediated neurotransmission (Cunningham
and Jones, 2000) which may explain the modulation of the N45
potential, a potential marker for GABAAR activity (Premoli et al.,
2014a,b; Darmani et al., 2016). In addition, the channels which
showed N45 significant changes were located contralateral to
the stimulated site, in line with the topographical modulation
induced by positive modulators of GABAAR (Premoli et al.,
2014a). Another key of interpretation may be a global shift of
the excitation/inhibition balance toward the latter, a common
mechanism of action for AEDs (Greenhill and Jones, 2010).
Future studies should assess whether lamotrigine-responsiveness
(i.e., seizure freedom) in patients with epilepsy is associated to
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FIGURE 2 | (A) TEPs measured post drug conditions with unadjusted (Post-drug with RMT1, blue) and adjusted (Post-drug with RMT2, red) intensity. Levetiracetam
(left) increased the N100 potential over the left hemisphere, while lamotrigine increased P25 and N45 peaks on channels contralateral to the stimulated left M1.
T-statistic maps of the TEP differences are shown. Blue represents increase in negativity (i.e., N100 and N45) and red increased positivity (i.e., P25) (B) Difference
between Post-drug with RMT2 and Post-drug with RMT1 for levetiracetam (blue) and lamotrigine (red) which showed a significant difference corresponding with the
N45 potential latency over contralateral sites as indicated in the t-statistic map. Black bars underneath each curve represent significant changes. Shades indicate ± 1
SEM. Each plot shows the grand-average across significant channels which are indicated by black dots in the t-statistic maps.
the N45 modulation, a candidate biological measure of treatment
outcome.
Of relevance to the second question, we refer to a previous
TMS/fMRI study which investigated the effects of lamotrigine
after threshold and suprathreshold TMS stimulation. In line with
our finding of a greater modulation at RMT2 levels, results
showed a reduction of TMS-induced BOLD activation of the
motor area after lamotrigine administration, with even stronger
effects when TMS was applied at 120% RMT compared to 100%
RMT (Li et al., 2004).
In the non-invasive brain stimulation field, the choice of
stimulation parameters such as intensity is of high relevance and
it is crucial for the outcome of investigational and therapeutic
studies (Fitzgerald et al., 2006). It becomes even a more
relevant challenge when targeting non-motor sites as it is
difficult to disentangle excitability changes of the stimulated
neural population. When designing experiments which
include post-drug or post-intervention RMT measurements,
it should be considered that RMT assessment can be time
consuming and may affect the investigation of short-term
after effect. In this particular study, the effects of the two
medications on cortical excitability lie in a wide time
window appropriate for post-drug investigations. It was
shown that the effects of lamotrigine (Tergau et al., 2003)
and levetiracetam (Epstein et al., 2008) on RMT remained
significantly elevated from 2 to 8 and 1 to 24 h post-dose,
respectively.
To conclude, we show that the increased stimulation intensity
determined a different mechanistic profile evaluated with
TEPs. Our results indicate that in future pharmaco-TMS-EEG
experiments a range of stimulation intensities should be used
in both pre- and post-drug conditions, in order to enable
comparison of TEPs between conditions using relative vs.
absolute stimulation intensity.
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